Interactive support messaging for women with recurrent pregnancy loss
Official title: A Single-arm Trial of a Web Based TLC (Tender Loving Care) Platform to Psychologically Support Patients With Recurrent Pregnancy Loss
Run by Walter Reed National Military Medical Center · NCT06182878 · Data updated 2026-11-12
This study tests if a weekly messaging program that offers support and advice can help women who have had multiple pregnancy losses have healthier pregnancies and feel better overall.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 44 Years |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Walter Reed National Military Medical Center Federal |
| Locations | 1 site (Bethesda, Maryland) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | April 22, 2026 |
| Trial ID | NCT06182878 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant individuals at less than or equal to 10 weeks gestation with a history of at least two prior pregnancy losses.
✕Probably not a fit
Patients with certain medical conditions, such as uterine anomalies or those who are current smokers, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This investigational study evaluates the impact of a weekly interactive messaging platform designed to provide tender loving care on pregnancy outcomes for individuals experiencing recurrent pregnancy loss. Participants will engage with messages that offer prenatal counseling and support while completing a fertility quality of life survey throughout their pregnancy. The study aims to determine if this intervention can increase live birth rates, enhance quality of life, and reduce depressive symptoms among participants.
Why it matters
Potential benefit: If successful, this approach could improve live birth rates and overall well-being for patients with recurrent pregnancy loss.
How similar studies have gone: While the specific approach of interactive messaging for this condition is novel, similar supportive interventions have shown promise in improving outcomes in other patient populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant individuals receiving their prenatal care at WRNMMC * Able to speak and understand English * Less than or equal to 10+0 weeks gestation by last menstrual period (LMP) or dating ultrasound at the time of enrollment * At least two prior pregnancy losses. Pregnancy losses must be confirmed with laboratory criteria confirming a positive pregnancy test in the military electronic medical record with subsequent resolution (resolution may be reported by patient), or with ultrasound criteria demonstrating an intrauterine gestational sac with subsequent resolution (resolution may be reported by patient). Exclusion Criteria: * Age less than 18 years and older than 44 at time of enrollment * Unable to speak or understand English * Current smoker or tobacco use within 30 days * History of uterine anomaly, coagulopathy, balanced translocation, endometrial polyps, submucosal fibroids, pathology confirmed acute or chronic endometritis, hydrosalpinx, history of Asherman syndrome, poorly controlled endocrinopathies, HIV infection * History of gonadotoxic therapy or cancerous condition of the female reproductive tract * Suspicion for or confirmation of an ectopic pregnancy
Where it's running
-
Walter Reed National Military Medical Center
Bethesda, Maryland, United States Recruiting
Study contacts
- Principal investigator: David Boedeker, DO — Walter Reed National Military Medical Center
- Study coordinator: David Boedeker, DO
- Email: david.h.boedeker.mil@health.mil
- Phone: 301-400-2140
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
G-CSF to help women with unexplained recurrent miscarriages
This study tests whether recombinant G-CSF can help women with two or more unexplained miscarriages who are undergoing IVF with tested embryos.
-
Effect of a 21-day comprehensive spa program on female infertility
This study tests whether a 21-day spa treatment can impact hormonal profiles and reproductive outcomes in women ages 20-40 with infertility.
-
Right DLPFC fNIRS neurofeedback for anxiety in women with recurrent pregnancy loss
This trial will see if right dorsolateral prefrontal cortex-targeted fNIRS closed-loop neurofeedback with slow-wave sound cues can reduce anxiety and improve heart-rate regulation in women with recurrent pregnancy loss aged 18–45.
-
Hydroxychloroquine plus levothyroxine for improving live birth in euthyroid women with recurrent pregnancy loss and TPO antibodies
This trial will test whether adding hydroxychloroquine to levothyroxine increases the chance of a live birth for euthyroid women who have thyroid peroxidase antibodies and a history of recurrent pregnancy loss.
-
Registry for patients with recurrent pregnancy loss
This study is collecting information from women who have had multiple pregnancy losses to see how different treatments and care options can help them over time.
-
Using prednisolone to help women with unexplained recurrent miscarriages
This study is testing if taking prednisolone can help women who have had multiple unexplained miscarriages have a successful pregnancy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.